Literature DB >> 22302798

Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

Haeman Jang1, David Boltz, Jennifer McClaren, Amar K Pani, Michelle Smeyne, Ane Korff, Robert Webster, Richard Jay Smeyne.   

Abstract

The A/VN/1203/04 strain of the H5N1 influenza virus is capable of infecting the CNS of mice and inducing a number of neurodegenerative pathologies. Here, we examined the effects of H5N1 on several pathological aspects affected in parkinsonism, including loss of the phenotype of dopaminergic neurons located in the substantia nigra pars compacta (SNpc), expression of monoamines and indolamines in brain, alterations in SNpc microglia number and morphology, and expression of cytokines, chemokines, and growth factors. We find that H5N1 induces a transient loss of the dopaminergic phenotype in SNpc and now report that this loss recovers by 90 d after infection. A similar pattern of loss and recovery was seen in monoamine levels of the basal ganglia. The inflammatory response in lung and different regions of the brain known to be targets of the H5N1 virus (brainstem, substantia nigra, striatum, and cortex) were examined at 3, 10, 21, 60, and 90 d after infection. In each of these brain regions, we found a significant increase in the number of activated microglia that lasted at least 90 d. We also quantified expression of IL-1α, IL-1β, IL-2, IL-6, IL-9, IL-10, IL-12(p70), IL-13, TNF-α, IFN-γ, granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, macrophage colony-stimulating factor, eotaxin, interferon-inducible protein 10, cytokine-induced neutrophil chemoattractant, monocyte chemotactic protein-1, macrophage inflammatory protein (MIP) 1α, MIP-1β, and VEGF, and found that the pattern and levels of expression are dependent on both brain region and time after infection. We conclude that H5N1 infection in mice induces a long-lasting inflammatory response in brain and may play a contributing factor in the development of pathologies in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302798      PMCID: PMC3307392          DOI: 10.1523/JNEUROSCI.5123-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

1.  Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease.

Authors:  Michelle Smeyne; Richard J Smeyne
Journal:  Brain Res Brain Res Protoc       Date:  2002-04

Review 2.  The impact of systemic infection on the progression of neurodegenerative disease.

Authors:  V Hugh Perry; Tracey A Newman; Colm Cunningham
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

3.  Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia.

Authors:  Alain R Simard; Serge Rivest
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

Review 4.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 5.  Macrophage inflammatory protein-1.

Authors:  Patricia Menten; Anja Wuyts; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

6.  1918 influenza, encephalitis lethargica, parkinsonism.

Authors:  R T Ravenholt; W H Foege
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

Review 7.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

Review 8.  The role of glial reaction and inflammation in Parkinson's disease.

Authors:  E C Hirsch; T Breidert; E Rousselet; S Hunot; A Hartmann; P P Michel
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

9.  Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice.

Authors:  Hiroko Tanaka; Chun-Ho Park; Ai Ninomiya; Hiroichi Ozaki; Ayato Takada; Takashi Umemura; Hiroshi Kida
Journal:  Vet Microbiol       Date:  2003-08-29       Impact factor: 3.293

10.  Analysis of cerebellar development in math1 null embryos and chimeras.

Authors:  Patricia Jensen; Richard Smeyne; Dan Goldowitz
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

View more
  48 in total

1.  Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.

Authors:  Qiang Liu; Nader Sanai; Wei-Na Jin; Antonio La Cava; Luc Van Kaer; Fu-Dong Shi
Journal:  Nat Neurosci       Date:  2016-01-11       Impact factor: 24.884

Review 2.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

3.  Chronic oral methylphenidate treatment increases microglial activation in rats.

Authors:  Emily Carias; John Hamilton; Lisa S Robison; Foteini Delis; Rina Eiden; Teresa Quattrin; Michael Hadjiargyrou; David Komatsu; Panayotis K Thanos
Journal:  J Neural Transm (Vienna)       Date:  2018-09-20       Impact factor: 3.575

Review 4.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

5.  Methylphenidate Causes Behavioral Impairments and Neuron and Astrocyte Loss in the Hippocampus of Juvenile Rats.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Matheus Grunevald; Letícia F Pettenuzzo; Giselli Scaini; Emilio L Streck; Carlos A Netto; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.590

Review 6.  Viral and inflammatory triggers of neurodegenerative diseases.

Authors:  Michela Deleidi; Ole Isacson
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

7.  Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.

Authors:  Stephen Blackmore; Jessica Hernandez; Michal Juda; Emily Ryder; Gregory G Freund; Rodney W Johnson; Andrew J Steelman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

8.  HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.

Authors:  M Smeyne; P Sladen; Y Jiao; I Dragatsis; R J Smeyne
Journal:  Neuroscience       Date:  2015-03-19       Impact factor: 3.590

9.  Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis.

Authors:  Susana V Bardina; Julia A Brown; Daniela Michlmayr; Kevin W Hoffman; Janet Sum; Alexander G Pletnev; Sergio A Lira; Jean K Lim
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

10.  Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection.

Authors:  Eamon D Quick; J Smith Leser; Penny Clarke; Kenneth L Tyler
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.